Disclosed herein are cannabinoid receptor ligands of formula (I)
wherein A1, A5, Rx, X4, and z are as defined in the specification. Compositions comprising such compounds, and methods for treating conditions and disorders using such compounds and compositions are also disclosed.
本文披露了公式(I)的
大麻素受体
配体,其中A1,A5,Rx,X4和z如规范中所定义。还披露了包含这些化合物的组合物,以及使用这些化合物和组合物治疗疾病和疾病的方法。